AzTrials
AzTrials

Intestinal MotilityNCT07764367

Evaluation the Effects of Chewing Gum

A study testing chewing gum in people with Intestinal Motility and Postpartum Satisfaction, run by Karabuk University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was conducted as a randomized controlled trial to evaluate the effects of gum chewing in the early postpartum period on bowel function, postpartum comfort, and postpartum satisfaction in women. The sample consisted of 66 women, 33 in the experimental group and 33 in the control group. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
What is being tested?
chewing gum
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Dec 2024to 30 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Women aged 18-45 years
  • Women who underwent cesarean section under epidural or spinal anesthesia

Who cannot join

  • Cesarean delivery under general anesthesia
  • Jaw or oral membrane problems that may prevent chewing gum
  • Any systemic or chronic disease
  • Any mental or psychiatric illness
  • History of chronic constipation
  • Any communication problems, including mental, auditory, or visual impairments

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Karabuk Training and Research Hospital

    Karabük, 78100

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluating the Effects of Chewing Gum on Bowel Function, Postpartum Comfort and Satisfaction With Caesarean Birth: A Randomized Controlled Trial

This study was conducted as a randomized controlled trial to evaluate the effects of gum chewing in the early postpartum period on bowel function, postpartum comfort, and postpartum satisfaction in women. The sample consisted of 66 women, 33 in the experimental group and 33 in the control group. Data were collected using a pre-assessment form, a demographic information form, a bowel function monitoring form, a postpartum comfort scale, and a maternal satisfaction scale (cesarean delivery). While the control group received no intervention other than standard postoperative care, the experimental group underwent gum chewing at 4, 6, and 8 hours postpartum.

Being tested
chewing gum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • chewing gumOther

    In addition to routine post-cesarean care, women in the experimental group were given commercially available sugar-free, aspartame-free, sorbitol-free, xylitol-free, soft, and easy-to-chew gum to chew from the 4th hour post-operatively until they switched to Diet I. Since oral feeding was started at the 6th hour in the clinic where the study was conducted, women in the experimental group were given gum to chew at the 4th, 6th, and 8th hours after cesarean section, with each chewing session lasting between 15 and 30 minutes. The women were instructed to chew their gum at the 6th hour post-cesarean and then drink water before starting oral feeding. The gum used in one period was not repeated in the next period; a new pack of gum was used. In this way, each woman chewed a total of 3 pieces of gum.

Study groups in NCT07764367
Study groupRoleWhat they receive
chewing gum groupExperimentalNot described
Receives: Other: chewing gum
no initiativeNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bowel motility (time to pass gas and stool)

    Measured: 2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).

  2. Maternal Satisfaction With Caesarean Birth Measured Using the Scale for Measuring Maternal Satisfaction-Caesarean Birth

    This measurement was evaluated using the Maternal Satisfaction Assessment Scale at Birth (Cesarean Birth). Developed by Güngör and Beji (2009) to assess the experiences of women in the early postpartum period after cesarean delivery, this scale consists of 42 items on a 5-point Likert scale with 10 sub-dimensions: perception of the healthcare team, preparation for cesarean section, reassurance, participation in decision-making and information sharing, meeting the baby, postpartum care, hospital room, hospital facilities, respect for privacy, and meeting expectations. Each item on the scale is scored between 1 (strongly disagree) and 5 (strongly agree). Twelve items (8, 9, 10, 19, 20, 21, 22, 34, 35, 37, 40, 41) are reverse-scored. The highest possible score is 210, and the lowest is 42. As the score on the scale increases, the level of satisfaction also increases.

    Measured: 2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).

  3. Postpartum Comfort Level Measured Using the Postpartum Comfort Scale (PCS)

    This measurement was evaluated using the Postpartum Comfort Scale. It is a scale developed by Karakaplan and Yıldız, based on Kolcaba's general comfort scale, and adapted for our country. It was developed to evaluate the comfort of women who have had cesarean and vaginal deliveries. The scale consists of 34 items with 3 sub-dimensions: sociocultural, psychospiritual, and physical, using a 5-point Likert scale. Each item is scored between 1 (strongly disagree) and 5 (strongly agree). The highest possible score on the scale is 170, and the lowest is 34. The Postpartum Comfort Scale and sub-dimension scores are evaluated based on the total score, and as the score increases, the comfort level of the women increases.

    Measured: 2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2026
  2. Study start10 Dec 2024
  3. Primary completion30 Sep 2025
  4. Study completion30 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07764367
Sponsor's protocol ID
2024-KAEK-82
Other IDs
KBÜBAP-25-YL-030
Status last verified
Aug 2026
First submitted
2 Aug 2026
Last updated
13 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing chewing gum in people with Intestinal Motility and Postpartum Satisfaction, run by Karabuk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bowel motility (time to pass gas and stool) (time frame: 2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in